Replies

The literature I’ve seen on Ivermectin has shown it to have little to no impact on those who are progressing from mild to moderate to severe illness. In fact, there is some evidence that those who are significantly susceptible to COVID-19 actually end up on a ventilator faster if they’re given Ivermectin (https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-06348-5).

In fact, the only positive literature I’ve seen on Ivermectin has either been with incredibly tiny groups or the study itself had major problems in its construction or execution. All of the larger (and there have not been any especially large, well controlled studies that I’m aware of) clinical studies have shown no statistically significant benefit with Ivermectin. And that matches up with the anecdotal reports I’ve heard from doctors who’ve tried using it with COVID-19 patients, including doctors right here on FR.

Monoclonal antibody therapy works. There’s a ton of research data backing that. FDA agrees. President Trump’s doctors agreed. That’s why when he went into the hospital seriously ill with COVID-19, they didn’t give him Ivermectin; they gave him monoclonal antibody therapy. And it worked. In fact, it works with most patients. It works best with patients in the earlier stages, but it can also turn around someone who’s on their way to the ICU or the grave. It’s not a perfect silver bullet, but it’s the closest thing we have.

So you see, it’s not that I’m against treatments, but I do want treatments backed by significant evidence. I’ve seen a lot of convincing evidence that Ivermectin is not an effective treatment, particularly for those already coming to the hospital. I have seen no convincing evidence so suggest Ivermectin has a significant benefit to it. That’s in start contrast to monoclonal antibody therapy.